KILITCH DRUGS Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KILITCH DRUGS Quarterly Results    (KHDG)

Here are the latest quarterly results of KILITCH DRUGS. For more details, see the KILITCH DRUGS financial fact sheet and KILITCH DRUGS share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

KILITCH DRUGS Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m104153159116102181203199 
Other income Rs m14671544415 
Turnover Rs m118159166131106185207214 
Expenses Rs m112136144139113151173196 
Gross profit Rs m-71715-23-1130303 
Depreciation Rs m45655555 
Interest Rs m22223212 
Profit before tax Rs m11715-16-15272812 
Tax Rs m335-3-2565 
Profit after tax Rs m-2139-12-1322227 
Gross profit margin %-7.011.29.6-19.8-10.916.414.91.6 
Effective tax rate %427.120.534.921.512.418.421.039.5 
Net profit margin %-1.98.75.9-10.7-13.112.210.73.5 
Diluted EPS Rs -0.1 0.9 0.6 -0.8 -0.9 1.4 1.4 0.5  
Diluted EPS (TTM) Rs NA NA 1.7 0.5 -0.2 0.4 1.2 2.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Pharmaceuticals Company Quarterly Results:   DENIS CHEM LAB  BIOCON   VASUNDHARA RASAYANS  GIAN LIFE CARE  BETA DRUGS   

Compare KILITCH DRUGS With:   DENIS CHEM LAB  BIOCON   VASUNDHARA RASAYANS  GIAN LIFE CARE  BETA DRUGS   



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

More Views on News

Most Popular

These Stocks Are Ready to Zoom (Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks (Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider (Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks (Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KILITCH DRUGS SHARE PRICE


Aug 5, 2021 03:35 PM

TRACK KILITCH DRUGS

  • Track your investment in KILITCH DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KILITCH DRUGS

KILITCH DRUGS 5-YR ANALYSIS

COMPARE KILITCH DRUGS WITH

MARKET STATS